Suitability of thoracic cytology for new therapeutic paradigms in non-small cell lung carcinoma: high accuracy of tumor subtyping and feasibility of EGFR and KRAS molecular testing - Rekhtman, N; Brandt, S M; Sigel, C S (J Thorac Oncol, 2011)
, et al.